|
James A. MacLennan was appointed Executive Vice President and Chief Financial Officer of Lodgian on March 15, 2006. Prior to joining Lodgian, Mr. MacLennan was Chief Financial Officer and Treasurer of Buford, GA-based Theragenics Corporation, a NYSE-listed company that manufactures medical devices used for treating prostate cancer. In addition to responsibility for the company's corporate finance activities and investor relations function, he provided critical leadership in Theragenic's merger and acquisition activities and product diversification initiatives. Previously, Mr. MacLennan was executive vice president and chief financial officer with Lanier Worldwide, Inc., a publicly held $1.4 billion technical products company, where he was responsible for all corporate finance activities. He played a major role in taking Lanier public and listing it on the New York Stock Exchange, then later in finding a longer-term strategic solution for Lanier. | 